Washington Trust Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-70
Closed -$522 699
2025
Q2
$522 Hold
70
﹤0.01% 629
2025
Q1
$426 Hold
70
﹤0.01% 635
2024
Q4
$545 Hold
70
﹤0.01% 641
2024
Q3
$568 Hold
70
﹤0.01% 656
2024
Q2
$484 Hold
70
﹤0.01% 655
2024
Q1
$1.24K Hold
70
﹤0.01% 649
2023
Q4
$1.08K Hold
70
﹤0.01% 657
2023
Q3
$960 Hold
70
﹤0.01% 664
2023
Q2
$1.21K Hold
70
﹤0.01% 644
2023
Q1
$1.68K Hold
70
﹤0.01% 739
2022
Q4
$1.21K Hold
70
﹤0.01% 756
2022
Q3
$2K Hold
70
﹤0.01% 846
2022
Q2
$2K Hold
70
﹤0.01% 869
2022
Q1
$2K Hold
70
﹤0.01% 939
2021
Q4
$4K Buy
+70
New +$4.84K ﹤0.01% 877

Other funds holding CYRX

Washington Trust Advisors's CYRX Position: Q3 2025 in Review

Washington Trust Advisors sold out of CryoPort (CYRX) in Q3 2025, closing a stake of 70 shares — an estimated $522 sold.

Washington Trust Advisors first reported a position in CYRX in Q4 2021 and held it in 15 quarters. The position peaked at $4K in Q4 2021. 160 funds tracked by Wall St. Rank hold CYRX as of Q3 2025.

  • Washington Trust Advisors reported no remaining CryoPort position as of Q3 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 70 CryoPort shares in Q3 2025, an estimated $522.
  • Washington Trust Advisors first reported a position in CryoPort in Q4 2021 and held it in 15 quarters.
  • Washington Trust Advisors's CryoPort position peaked at $4K in Q4 2021.
  • 160 funds tracked by Wall St. Rank held CryoPort as of Q3 2025.

Based on Washington Trust Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.